Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Restructuring Costs came in at $9.0 million in Q2 2026, down 70.97% year-over-year from $31.0 million in Q2 2025, and down 30.77% quarter-over-quarter from $13.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Restructuring Costs across 18 years of filings, most recently posting $9.0 million for Q2 2026.
- In Q2 2026, Restructuring Costs fell 70.97% year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $67.0 million (up 67.5% YoY), while the FY2025 annual figure was $77.0 million, up 140.62% from the prior year.
- Restructuring Costs came in at $9.0 million for Q2 2026 at Bausch Health Companies, down from $13.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $35.0 million in Q2 2022 to a low of $1.0 million in Q3 2024.
- Average Restructuring Costs over 5 years is $14.2 million, with a median of $12.5 million recorded in 2022.
- Year-over-year, Restructuring Costs slumped 92.86% in 2024 and surged 1600.0% in 2025.
- Over 5 years, Restructuring Costs stood at $5.0 million in 2022, then jumped by 340.0% to $22.0 million in 2023, then plunged by 68.18% to $7.0 million in 2024, then surged by 300.0% to $28.0 million in 2025, then slumped by 67.86% to $9.0 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $9.0 million in Q2 2026, $13.0 million in Q1 2026, and $28.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 28.00 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 31.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 22.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 16.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 8.00 Mn |